New York · Nonprofit
NEW YORK GENOME CENTER INC
NEW YORK GENOME CENTER INC (New York) receives grants from 46 organizations whose IRS filings report $210,920,619 to it, the largest being THE SIMONS FOUNDATION INC ($104,549,822). 28 of them have funded it in more than one year.
- Revenue FY2024
- $82M
- Funders on record
- 46
- Grants received
- $211M
- Net assets
- $44M
What New York Genome Center Inc does
Mission
Operate a state-of-the-art, world-class genomic research center that creates and uses advanced genomics to understand the genetic basis of disease. For more information, see schedule o.
As stated on its FY2024 Form 990.
Programs
Genome sequencing: the new york genome center (nygc) has one of new york's largest and most advanced whole genome sequencing programs, having sequenced over 106,885 whole genome samples to date. Nygc's two state-of-the-art illumina novaseq x systems sequencers are each capable of sequencing 20,000 human genomes annually. This state-of-the-art sequencing technology enables nygc to conduct large-scale genomics projects with great speed and sample volumes, and to explore the genome in more depth with greater efficiency. In addition, nygc operates an oxford nanopore promethion sequencer for long read sequencing, and a high-throughput sequencer from ultima genomics (the ug100). See schedule o.
$60,479,500 spentof which $2,986,182 as grants$4,233,105 earned by the program89% of program spendingClinical sequencing: nygc's clep/clia certified clinical laboratory is authorized by the new york state department of health to offer the following approved clinical tests: constitutional whole genome sequencing for undiagnosed disease, constitutional whole genome sequencing for predispositional genetic screening, oncology whole genome and transcriptome sequencing, targeted variant testing using sanger sequencing, maternal cell contamination testing, and aneuploidy screening.
$7,674,355 spent$671,814 earned by the program11% of program spending
The 2 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $68,153,855.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $85M to $182M (+113%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2017 23% · 2018 24% · 2019 45% · 2020 21% · 2021 20% · 2022 22% · 2023 24% · 2024 27%. Grants only. Government contracts and fees sit inside program revenue.
92% of NEW YORK GENOME CENTER INC’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Tom Maniatis Phd
Scientific director & CEO
As listed on its FY2024 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 6 funders to 20 funders, grant income rose $3.2M → $46M.
10 of 46 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 8% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $13M from 4 payers (the payer shares this organization's board, largest Jewish Communal Fund). These are real filings, and they are not money NEW YORK GENOME CENTER INC raised.
From the IRS filings of NEW YORK GENOME CENTER INC’s funders (the co-funder graph). Top 30 of 46 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
NEW YORK GENOME CENTER INC leans on a few funders — its largest provides 50% of grant income and the top three 70%; half comes from just 2 funders.
the vertical line marks half of all grant income — 2 funders to its left
Largest funder’s share by year: 2017 49% · 2018 42% · 2019 31% · 2020 71% · 2021 61% · 2022 55% · 2023 44% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
46% of NEW YORK GENOME CENTER INC's funders are still giving 3 years after their first grant; 61% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
87% of NEW YORK GENOME CENTER INC's grant income comes from New York funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $16M arriving through sponsors registered in 7 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
NEW YORK GENOME CENTER INC's funding base is broadening — from 6 funders to 20 as grant income climbed.
this organization peer median middle 50% of peers· 4,580 health nonprofits $10M–$100M, FY2024
Government funding NEW YORK GENOME CENTER INC receives
Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $175.8M on record.
- Department of Health and Human Services$172.3M
- Department of Defense$2.2M
- Department of Veterans Affairs$968k
- National Science Foundation$320k
Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.
Organizations like NEW YORK GENOME CENTER INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
81% of spending goes to programs.
Governance
Public support
57%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 38 states
Screen this organization
A dated, signed PDF of the compliance screen for NEW YORK GENOME CENTER INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds NEW YORK GENOME CENTER INC?
- NEW YORK GENOME CENTER INC (New York) receives grants from 46 organizations whose IRS filings report $210,920,619 to it, the largest being THE SIMONS FOUNDATION INC ($104,549,822). 28 of them have funded it in more than one year.
- How many funders does NEW YORK GENOME CENTER INC have?
- IRS filings report 46 organizations giving $210,920,619 in grants to NEW YORK GENOME CENTER INC, 28 of which have funded it in more than one year.
- Who is the largest funder of NEW YORK GENOME CENTER INC?
- THE SIMONS FOUNDATION INC is the largest funder on record, with $104,549,822 in grants. The full list of funders is on this page.
- How can an organization like NEW YORK GENOME CENTER INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 46 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing